RT Journal Article
SR Electronic
T1 Integrative lipidomics and metabolomics for system-level understanding of the metabolic syndrome in long-term treated HIV-infected individuals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.04.21256640
DO 10.1101/2021.05.04.21256640
A1 Sofie Olund Villumsen
A1 Rui Benfeitas
A1 Andreas Dehlbæk Knudsen
A1 Marco Gelpi
A1 Julie Høgh
A1 Magda Teresa Thomsen
A1 Daniel Murray
A1 Henrik Ullum
A1 Ujjwal Neogi
A1 Susanne Dam Nielsen
YR 2021
UL http://medrxiv.org/content/early/2021/05/08/2021.05.04.21256640.abstract
AB People living with HIV (PLWH) require life-long anti-retroviral treatment and often present with comorbidities such as metabolic syndrome (MetS). A systematic lipidomic characterization and its association with metabolism is currently missing. In this study, we included 100 PLWH with MetS and 100 without MetS from the Copenhagen comorbidity in HIV infection (COCOMO) cohort to examine whether and how lipidome profiles associated with MetS in PLWH. We combined several standard biostatistical, machine learning, and network analysis techniques to investigate the lipidome systematically and comprehensively. Our observations indicate an increased abundance of the glycerolipids and an association between structural composition patterns of glycerolipids in PLWH with MetS. Further integration of the key metabolites identified earlier in the same population and clinical data with lipidomics suggest disruption of the glutamate and fatty acid metabolism. suggest their involvement in pathogenesis of PLWH with MetS.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is explorative cross-sectional studiesFunding StatementThe study is funded by Rigshospitalet Research Council, Danish National Research Foundation (DNRF126) NovoNordisk Foundation. UN acknowledge the support received from Swedish Research Council Grants (2017-01330 and 2018-06156).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained by the Regional Ethics Committee of Copenhagen (COCOMO: H-15017350). Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and Code Availability: The lipidomics data datacan be obtained from the dx.doi.org/ 10.6084/m9.figshare.14509452 All the codes are available at github: https://github.com/neogilab/COCOMO_lipidomics https://figshare.com/articles/dataset/_/14509452 https://figshare.com/articles/dataset/_/14356754